From: Paula Fukushima (pif@mail.nih.gov)
Date: Fri May 24 2002 - 08:40:01 EST
Hi List,
Does anyone have an idea of B cell antibodies to use to follow disease
in B cell lymphomas
with patients now being given anti-CD22(Epratuzumab) and
anti-CD20(Rituxamab) besides CD19?
Thanks, Paula
Paula Imus
Flow Cytometry
LP, NCI, NIH
10 Center Drive MSC-1500
Bethesda, Md. 20892-1500
This archive was generated by hypermail 2.1.6 : Thu Jan 01 2004 - 17:41:43 EST